Abstract: Sentinel lymph nodes (SLNs) are the first station of lymph nodes that extend from the breast tumor to the axillary lymphatic drainage. The pathological status of these LNs can predict that of the entire axillary lymph node. Therefore, the accurate identification of SLNs is necessary for sentinel lymph node biopsy (SLNB) to replace axillary lymph node dissection (ALND). The quality of life and prognosis of breast cancer patients are related to proper surgical treatment after the precise identification of SLNs. Some of the SLN tracers that have been identified include radioisotope, nano-carbon, indocyanine green (ICG), and methylene blue (MB). However, these tracers have certain limitations, such as pigmentation, radiation dangers, and the requirement for costly detection equipment. Ultrasound contrast agents (UCAs) have good specificity and sensitivity, and thus can compensate for some shortcomings of the mentioned tracers. This technique is also being applied to SLNB in patients with breast cancer, and can even provide an initial judgment on SLN status. Contrast-enhanced ultrasound (CEUS) has the advantages of high distinguishability, simple operation, no radiation harm, low cost, and accurate localization; therefore, it is expected to replace the traditional biopsy methods. In addition, it can significantly enhance the accuracy of SLN localization and shorten the operation time.

超声造影在乳腺癌前哨淋巴结定位和诊断中的优势

[1]BallalH, HuntC, BharatC, et al., 2018. Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection. ANZ J Surg, 88(9):917-921.

[2]BassSS, CoxCE, KuNN, et al., 1999. The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg, 189(2):183-194.

[3]BelmonteR, Messaggi-SartorM, FerrerM, et al., 2018. Prospective study of shoulder strength, shoulder range of motion, and lymphedema in breast cancer patients from pre-surgery to 5 years after ALND or SLNB. Support Care Cancer, 26(9):3277-3287.

[4]CantisaniV, BertolottoM, WeskottHP, et al., 2015. Growing indications for CEUS: the kidney, testis, lymph nodes, thyroid, prostate, and small bowel. Eur J Radiol, 84(9):1675-1684.

[5]CaproniN, MarchisioF, PecchiA, et al., 2010. Contrast-enhanced ultrasound in the characterisation of breast masses: utility of quantitative analysis in comparison with MRI. Eur Radiol, 20(6):1384-1395.

[6]ChenC, WangY, NiuJW, et al., 2021. Domain knowledge powered deep learning for breast cancer diagnosis based on contrast-enhanced ultrasound videos. IEEE Trans Med Imaging, 40(9):2439-2451.

[7]ChenWQ, ZhengRS, ZhangSW, et al., 2017. Cancer incidence and mortality in China, 2013. Cancer Lett, 401‍:‍63-71.

[8]CuiQX, DaiL, LiJL, et al., 2020. Accuracy of CEUS-guided sentinel lymph node biopsy in early-stage breast cancer: a study review and meta-analysis. World J Surg Oncol, 18:112.

[9]CuiXW, IgneeA, NielsenMB, et al., 2013. Contrast enhanced ultrasound of sentinel lymph nodes. J Ultrason, 13(52):73-81.

[10]CwalinskiT, PolomW, MaranoL, et al., 2020. Methylene blue—current knowledge, fluorescent properties, and its future use. J Clin Med, 9(11):3538.

[11]DuJ, LiFH, FangH, et al., 2008. Microvascular architecture of breast lesions: evaluation with contrast-enhanced ultrasonographic micro flow imaging. J Ultrasound Med, 27(6):833-842.

[12]DuX, ZhangJJ, LiuL, et al., 2022. A novel anticancer property of Lycium barbarum polysaccharide in triggering ferroptosis of breast cancer cells. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 23(4):286-299.

[13]Garcia-EtienneCA, FerrariA, Della ValleA, et al., 2020. Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: an evidence-based update in a european breast center. Eur J Surg Oncol, 46(1):15-23.

[14]GhergheM, BordeaC, BlidaruA, 2015. Sentinel lymph node biopsy (SLNB) vs. axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer. J Med Life, 8(2):176-180.

[15]GoldbergBB, MertonDA, LiuJB, et al., 2004. Sentinel lymph nodes in a swine model with melanoma: contrast-enhanced lymphatic US. Radiology, 230(3):727-734.

[16]GolematiS, CokkinosDD, 2022. Recent advances in vascular ultrasound imaging technology and their clinical implications. Ultrasonics, 119:106599.

[17]GrischkeEM, RöhmC, HahnM, et al., 2015. ICG fluorescence technique for the detection of sentinel lymph nodes in breast cancer: results of a prospective open-label clinical trial. Geburtshilfe Frauenheilkd, 75(9):935-940.

[18]GuLS, ZhangR, WangY, et al., 2019. Characteristics of contrast-enhanced ultrasonography and strain elastography of locally advanced breast cancer. J Thorac Dis, 11(12):5274-5289.

[19]GuoJB, WangBH, HeMN, et al., 2022. Contrast-enhanced ultrasonography for early prediction of response of neoadjuvant chemotherapy in breast cancer. Front Oncol, 12:1026647.

[20]HaoYX, SunY, LeiYT, et al., 2021. Percutaneous Sonazoid-enhanced ultrasonography combined with in vitro verification for detection and characterization of sentinel lymph nodes in early breast cancer. Eur Radiol, 31(8):5894-5901.

[21]HuZY, ChengXQ, LiJ, et al., 2020. Preliminary study of real-time three-dimensional contrast-enhanced ultrasound of sentinel lymph nodes in breast cancer. Eur Radiol, 30(3):1426-1435.

[22]HuangSY, ZhaoYN, JiangX, et al., 2021. Clinical utility of contrast-enhanced ultrasound for the diagnosis of lymphadenopathy. Ultrasound Med Biol, 47(4):869-879.

[23]HuangYX, LeJ, MiaoAY, et al., 2021. Prediction of treatment responses to neoadjuvant chemotherapy in breast cancer using contrast-enhanced ultrasound. Gland Surg, 10(4):1280-1290.

[24]IoannidisGS, GoumenakisM, StefanisI, et al., 2022. Quantification and classification of contrast enhanced ultrasound breast cancer data: a preliminary study. Diagnostics (Basel), 12(2):425.

[25]KearnsKN, SokolowskiJD, ChadwellK, et al., 2019. The role of contrast-enhanced ultrasound in neurosurgical disease. Neurosurg Focus, 47(6):E8.

[26]Kemp JacobsenK, O'MearaES, KeyD, et al., 2015. Comparing sensitivity and specificity of screening mammography in the United States and Denmark. Int J Cancer, 137(9):2198-2207.

[27]KitaiT, KawashimaM, 2012. Transcutaneous detection and direct approach to the sentinel node using axillary compression technique in ICG fluorescence-navigated sentinel node biopsy for breast cancer. Breast Cancer, 19(4):343-348.

[28]KrynyckyiBR, MinerM, RagoneseJM, et al., 2000. Technical aspects of performing lymphoscintigraphy: optimization of methods used to obtain images. Clin Nucl Med, 25(12):978-985.

[29]LeeSC, TchelepiH, GrantE, et al., 2019. Contrast-enhanced ultrasound imaging of breast masses: adjunct tool to decrease the number of false-positive biopsy results. J Ultrasound Med, 38(9):2259-2273.

[30]LeeYJ, KimSH, KangBJ, et al., 2019. Contrast-enhanced ultrasound for early prediction of response of breast cancer to neoadjuvant chemotherapy. Ultraschall Med, 40(2):194-204.

[31]LiJ, LuM, ChengXQ, et al., 2019. How pre-operative sentinel lymph node contrast-enhanced ultrasound helps intra-operative sentinel lymph node biopsy in breast cancer: initial experience. Ultrasound Med Biol, 45(8):1865-1873.

[32]LiJ, LiH, GuanL, et al., 2022. The value of preoperative sentinel lymph node contrast-enhanced ultrasound for breast cancer: a large, multicenter trial. BMC Cancer, 22:455.

[33]LiuJ, LiuXL, HeJ, et al., 2019. Percutaneous contrast-enhanced ultrasound for localization and diagnosis of sentinel lymph node in early breast cancer. Sci Rep, 9:13545.

[34]LuoJ, FengLT, ZhouQ, et al., 2021. The value of contrast-enhanced ultrasound in determining the location of sentinel lymph nodes in breast cancer. Cancer Imaging, 21:28.

[35]LuoYH, ChenJ, FengLT, et al., 2022. Study on sentinel lymph node and its lymphatic drainage pattern of breast cancer by contrast-enhanced ultrasound. J Ultrasound Med, 41(11):2727-2737.

[36]MacDonaldAJ, ArkillKP, TaborGR, et al., 2008. Modeling flow in collecting lymphatic vessels: one-dimensional flow through a series of contractile elements. Am J Physiol Heart Circ Physiol, 295(1):H305-H313.

[37]MachadoP, StanczakM, LiuJB, et al., 2018. Subdermal ultrasound contrast agent injection for sentinel lymph node identification: an analysis of safety and contrast agent dose in healthy volunteers. J Ultrasound Med, 37(7):1611-1620.

[38]MachadoP, LiuJB, NeedlemanL, et al., 2023a. Sentinel lymph node identification in patients with breast cancer using lymphosonography. Ultrasound Med Biol, 49(2):616-625.

[39]MachadoP, LiuJB, NeedlemanL, et al., 2023b. Sentinel lymph node identification in post neoadjuvant chemotherapy breast cancer patients undergoing surgical excision using lymphosonography. J Ultrasound Med, 42(7):1509-1517.

[40]MagnoniF, GalimbertiV, CorsoG, et al., 2020. Axillary surgery in breast cancer: an updated historical perspective. Semin Oncol, 47(6):341-352.

[41]MajlesaraA, GolrizM, HafeziM, et al., 2017. Indocyanine green fluorescence imaging in hepatobiliary surgery. Photodiagn Photodyn Ther, 17:208-215.

[42]MattreyRF, KonoY, BakerK, et al., 2002. Sentinel lymph node imaging with microbubble ultrasound contrast material. Acad Radiol, 9(Suppl 1):S231-S235.

[43]MonleonS, FerrerM, TejeroM, et al., 2016. Shoulder strength changes one year after axillary lymph node dissection or sentinel lymph node biopsy in patients with breast cancer. Arch Phys Med Rehabil, 97(6):953-963.

[44]MoodyAN, BullJ, CulpanAM, et al., 2017. Preoperative sentinel lymph node identification, biopsy and localisation using contrast enhanced ultrasound (CEUS) in patients with breast cancer: a systematic review and meta-analysis. Clin Radiol, 72(11):959-971.

[45]NiuZH, GaoYJ, XiaoMS, et al., 2023. Contrast-enhanced lymphatic US can improve the preoperative diagnostic performance for sentinel lymph nodes in early breast cancer. Eur Radiol, 33(3):1593-1602.

[46]NtouliaA, AnupindiSA, BackSJ, et al., 2021. Contrast-enhanced ultrasound: a comprehensive review of safety in children. Pediatr Radiol, 51(12):2161-2180.

[47]OmotoK, HozumiY, OmotoY, et al., 2006. Sentinel node detection in breast cancer using contrast-enhanced sonography with 25% albumin—initial clinical experience. J Clin Ultrasound, 34(7):317-326.

[48]OmotoK, MatsunagaH, TakeN, et al., 2009. Sentinel node detection method using contrast-enhanced ultrasonography with Sonazoid in breast cancer: preliminary clinical study. Ultrasound Med Biol, 35(8):1249-1256.

[49]ParksRM, CheungKL, 2017. Axillary reverse mapping in N0 patients requiring sentinel lymph node biopsy—a systematic review of the literature and necessity of a randomised study. Breast, 33:57-70.

[50]PeekMC, CharalampoudisP, AnningaB, et al., 2017. Blue dye for identification of sentinel nodes in breast cancer and malignant melanoma: a systematic review and meta-analysis. Future Oncol, 13(5):455-467.

[51]QiuSQ, ZhangGJ, JansenL, et al., 2018. Evolution in sentinel lymph node biopsy in breast cancer. Crit Rev Oncol Hematol, 123:83-94.

[52]Safai ZadehE, DietrichCF, KmothL, et al., 2022. Peripheral pulmonary lesions in confirmed pulmonary arterial embolism: follow-up study of B-mode ultrasound and of perfusion patterns using contrast-enhanced ultrasound (CEUS). J Ultrasound Med, 41(7):1713-1721.

[53]SaidhaNK, AggarwalR, SenA, 2018. Identification of sentinel lymph nodes using contrast-enhanced ultrasound in breast cancer. Indian J Surg Oncol, 9(3):355-361.

[54]SaraccoA, SzabóBK, AspelinP, et al., 2012. Differentiation between benign and malignant breast tumors using kinetic features of real-time harmonic contrast-enhanced ultrasound. Acta Radiol, 53(4):382-388.

[55]SchwarzeV, MarschnerC, de FigueiredoGN, et al., 2020. Single-center study: evaluating the diagnostic performance and safety of contrast-enhanced ultrasound (CEUS) in pregnant women to assess hepatic lesions. Ultraschall Med, 41(1):29-35.

[56]ShimazuK, ItoT, UjiK, et al., 2017. Identification of sentinel lymph nodes by contrast-enhanced ultrasonography with Sonazoid in patients with breast cancer: a feasibility study in three hospitals. Cancer Med, 6(8):‍1915-1922.

[57]SorrentiS, DolcettiV, FresilliD, et al., 2021. The role of CEUS in the evaluation of thyroid cancer: from diagnosis to local staging. J Clin Med, 10(19):4559.

[58]TjoK, VaraminiP, 2022. Nanodiamonds and their potential applications in breast cancer therapy: a narrative review. Drug Deliv Transl Res, 12(5):1017-1028.

[59]TokiA, NiikuraH, MoriN, et al., 2021. Establishment of a diagnostic method for pelvic sentinel lymph node metastasis by contrast-enhanced ultrasound in uterine cancer. Ultrasound Med Biol, 47(8):2107-2116.

[60]VtorushinS, DulesovaA, KrakhmalN, 2022. Luminal androgen receptor (LAR) subtype of triple-negative breast cancer: molecular, morphological, and clinical features. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 23(8):617-624.

[61]WangJ, ChuYH, WangBH, et al., 2021. A narrative review of ultrasound technologies for the prediction of neoadjuvant chemotherapy response in breast cancer. Cancer Manag Res, 13:7885-7895.

[62]WangLN, LiJT, QiaoJH, et al., 2021. Establishment of a model for predicting sentinel lymph node metastasis in early breast cancer based on contrast-enhanced ultrasound and clinicopathological features. Gland Surg, 10(5):‍‍1701-1712.

[63]WangLY, ZhengSS, 2019. Advances in low-frequency ultrasound combined with microbubbles in targeted tumor therapy. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 20(4):291-299.

[64]WangXJ, TangLN, HuangWQ, et al., 2021. The combination of contrast-enhanced ultrasonography with blue dye for sentinel lymph node detection in clinically negative node breast cancer. Arch Gynecol Obstet, 304(6):‍1551-1559.

[65]WenBJ, KongWT, ZhangYD, et al., 2022. Association between contrast-enhanced ultrasound characteristics and molecular subtypes of breast cancer. J Ultrasound Med, 41(8):2019-2031.

[66]XieF, ZhangDJ, ChengL, et al., 2015. Intradermal microbubbles and contrast-enhanced ultrasound (CEUS) is a feasible approach for sentinel lymph node identification in early-stage breast cancer. World J Surg Oncol, 13:‍319.

[67]YangBL, ZhengSY, HuangXY, et al., 2021. A single-center, self-controlled, phase I clinical trial of mitoxantrone hydrochloride injection for lymph tracing for sentinel lymph node identification of breast cancer. Gland Surg, 10(3):992-1001.

[68]YinL, AgyekumEA, ZhangQ, et al., 2022. Differentiation between granulomatous lobular mastitis and breast cancer using quantitative parameters on contrast-enhanced ultrasound. Front Oncol, 12:876487.

[69]YuCC, LiY, ChenGP, et al., 2022. Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer: opportunities and challenges. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 23(7):547-563.

[70]YuanZ, QuanJ, YunxiaoZ, et al., 2013. Diagnostic value of contrast-enhanced ultrasound parametric imaging in breast tumors. J Breast Cancer, 16(2):208-213.

[71]ZaheerS, ShahN, MaqboolSA, et al., 2019. Estimates of past and future time trends in age-specific breast cancer incidence among women in Karachi, Pakistan: 2004-2025. BMC Public Health, 19:1001.

[72]ZhaiHY, LiangP, YuJ, et al., 2019. Comparison of Sonazoid and SonoVue in the diagnosis of focal liver lesions: a preliminary study. J Ultrasound Med, 38(9):2417-2425.

[73]ZhaoJ, ZhangJ, ZhuQL, et al., 2018. The value of contrast-enhanced ultrasound for sentinel lymph node identification and characterisation in pre-operative breast cancer patients: a prospective study. Eur Radiol, 28(4):1654-1661.

[74]ZhengJJ, RenWZ, ChenTX, et al., 2018. Recent advances in superparamagnetic iron oxide based nanoprobes as multifunctional theranostic agents for breast cancer imaging and therapy. Curr Med Chem, 25(25):3001-3016.

[75]ZhouSC, LeJ, ZhouJ, et al., 2020. The role of contrast-enhanced ultrasound in the diagnosis and pathologic response prediction in breast cancer: a meta-analysis and systematic review. Clin Breast Cancer, 20(4):e490-e509.